Fc receptor-like 1 (FCRL1) is a novel biomarker for prognosis and a possible therapeutic target in diffuse large B-cell lymphoma.

Yousefi, Zahra; Sharifzadeh, Sedigheh; Zare, Farahnaz; Eskandari, Nahid

Yousefi, Zahra; Sharifzadeh, Sedigheh; Zare, Farahnaz; Eskandari, Nahid.

Afiliación

Yousefi Z; School of Allied Medical Sciences, Shahroud University of Medical Sciences, Shahroud, Iran.
Sharifzadeh S; Division of Medical Biotechnology, Department of Medical Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Zare F; Diagnostic Laboratory Sciences and Technology Research Center, Faculty of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Eskandari N; Division of Medical Biotechnology, Department of Medical Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.

Mol Biol Rep ; 50(2): 1133-1145, 2023 Feb.

Article en En | MEDLINE | ID: mdl-36409389

Asunto(s)

Linfoma de Células B Grandes Difuso; FN-kappa B; Humanos; FN-kappa B/metabolismo; Proteínas Proto-Oncogénicas c-akt/genética; Proteínas Proto-Oncogénicas c-akt/metabolismo; Linfoma de Células B Grandes Difuso/genética; Linfoma de Células B Grandes Difuso/patología; Apoptosis/genética; Proliferación Celular/genética; Biomarcadores; Fosfatidilinositol 3-Quinasas/genética; Receptores Fc; Línea Celular Tumoral; Proteínas de la Membrana

Palabras clave

Apoptosis; Cell cycle; Diffuse large B-cell lymphoma (DLBCL); Fc receptor-like 1(FCRL1); PI3K/p-Akt; Proliferation; p65 NF-κB

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: FN-kappa B / Linfoma de Células B Grandes Difuso Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Biol Rep Año: 2023 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google